South Korean AI healthcare provider Lunit has secured a four-year national framework agreement in France for its breast imaging AI solutions.
This agreement enables the company's AI-powered breast imaging solutions to be available in more than 1,500 public hospitals nationwide.
The AI mammography tender was led by Union des Hôpitaux pour les Achats (UniHA), the central public procurement authority for hospitals in France.
The agreement encompasses Lunit's INSIGHT MMG and DBT software for mammography and digital breast tomosynthesis. These solutions are offered via the main contractor, Fujifilm.
This arrangement eliminates the need for separate tender processes for hospitals participating in the French public healthcare system.
The framework agreement dismantles obstacles to nationwide adoption and confirms the company's clinical potential in competitive markets.
UniHA biomedical engineering programme head Bertrand Lepage said: "We are seeing growing interest from institutions in our network in AI solutions for mammography. It is in this context that we launched this call for tenders, accompanied by demanding technical specifications.
"Our goal is to guarantee the public sector access to the best technologies available on the market, under conditions that are fair to those of the private sector.”
UniHA facilitates centralised purchases for more than 1,500 public hospitals and over 130 regional hospital groups. This helps to accelerate the adoption of innovative healthcare technologies across France's public healthcare network.
Lunit CEO Brandon Suh said: "Being selected under this national framework opens the door for Lunit to scale our AI solutions across France's public hospitals like never before.
"Winning this highly competitive tender, especially in collaboration with long-standing partner Fujifilm, underscores our proven value in breast cancer screening and reinforces our credibility within one of Europe's most strategic public markets.
"France is a priority market for us, and we're thrilled to strengthen our foothold through this agreement. With UniHA's endorsement, we're now in a stronger position to support nationwide breast cancer screening with advanced, AI-driven insights."
